close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about disease

Recent news which mentions disease

Cancer Centers Race To Access Revolution Medicines' Pancreatic Cancer Treatment: Report
Tickers NEWS RVMD
Tags disease cancer Large Cap
From Benzinga
Protara Therapeutics Reports 55% Complete Response Rate In Bladder Cancer Study
Tickers TARA
Tags Biotech TARA Movers
From Benzinga
REGENXBIO Advances Duchenne Gene Therapy Toward Accelerated Approval
Tickers NEWS RGNX
Tags Biotech Benzinga Movers
From Benzinga
Recursion Eyes Breakthrough With REC-4881 Drug For Rare Genetic Condition, But Shares Pull Back
Tickers RXRX
Tags Market News Health Care Trading Ideas
From Benzinga
Penny Stock Oncolytics Biotech Says Colorecatal Cancer Drug's Durability Tops Historical Benchmarks
Tickers NEWS ONCY
Tags Penny Stocks why it's moving Retail Investor Stocks
From Benzinga
Gilead's Lenacapavir Plan Faces Global Hurdles As It Commits To No-Profit Access for 2 Million
Tickers GILD NEWS
Tags Pharmaceutical Large Cap disease
From Benzinga
Capricor Reports 4-Year Data For Deramiocel, Shows Sustained Benefit In Duchenne Patients
Tickers CAPR NEWS
Tags News Health Care Market News
From Benzinga
European Advisory Panel Backs Conditional Approval For Madrigal's Fatty Liver Disease Drug
Tickers MDGL NEWS
Tags Briefs disease Large Cap
From Benzinga
Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision
Tickers NEWS OMER
Tags Biotech Markets Benzinga
From Benzinga
Pfizer, Arvinas Partnered Breast Cancer Drug Cuts Progression Risk By 43% In Trial, Seeks FDA Approval
Tickers ARVN NEWS PFE
Tags Health Care Market News General
From Benzinga
Valneva's Chikungunya Vaccine Advances With Pediatric Trial, Phase 3 In 2026
Tickers NEWS VALN
Tags disease VALN Briefs
From Benzinga
Jazz Pharma's Zepzelca Combo Shows Survival Edge In Lung Cancer Study
Tickers JAZZ NEWS RHHBY
Tags RHHBY Biotech Briefs
From Benzinga
Trevi Therapeutics Showcases Drug That Cuts Cough Frequency In Lung Disease Patients
Tickers TRVI
Tags why it's moving Briefs Benzinga
From Benzinga
Bicara Therapeutics Shares Sink Over 43% On Mixed Phase 1/1b Trial Results: What's Going On?
Tickers BCAX NEWS
Tags News Health Care cancer
From Benzinga
Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine
Tickers NEWS VALN
Tags Movers Global Benzinga
From Benzinga
Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
Tickers AZN BMY NEWS RHHBY
Tags TPST Briefs bristol myers squibb
From Benzinga
Cartesian Therapeutics Reports Strong 12-Month Data For Lead Cell Therapy In Myasthenia Gravis Patients
Tickers NEWS RNAC
Tags Benzinga Briefs Biotech
From Benzinga
Edgewise Therapeutics Sees Meaningful HCM Treatment Gains With EDG-7500 In Phase 2 Study
Tickers EWTX NEWS
Tags General Trading Ideas Market News
From Benzinga
Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data
Tickers NEWS VRTX
Tags Benzinga Biotech General
From Benzinga
Why Is Portage Biotech Stock Skyrocketing Friday?
Tickers NEWS PRTG
Tags General Trading Ideas Health Care
From Benzinga
FDA Approves Exelixis' Lead Cancer Drug Cabometyx For Expanded Use In Neuroendocrine Tumors
Tickers BMY EXEL NEWS PFE
Tags Benzinga PFE Biotech
From Benzinga
Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology
Tickers CRNX NEWS
Tags Benzinga Alex Thompson Biotech
From Benzinga
Johnson & Johnson's Golden Cross: Technical Momentum Meets Groundbreaking Lung Cancer Breakthrough
Tickers JNJ
Tags Golden Cross Biotech lung cancer
From Benzinga
Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial
Tickers RGNX
Tags Pharmaceutical disease Market News
From Benzinga
AbbVie's Elahere Cuts Death Risk By 32%, Shows Consistent Survival Benefit In Long-Term Analysis For Certain Ovarian Cancer Patients
Tickers ABBV NEWS
Tags Briefs Large Cap disease
From Benzinga
Avidity Biosciences Touts Positive Data From Early-Stage Duchenne Muscular Dystrophy Study Data, FDA Submission Expected By End Of 2025
Tickers NEWS RNA
Tags Briefs Benzinga RNA
From Benzinga
Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types
Tickers MRK PLRX
Tags MRK why it's moving Briefs
From Benzinga
Scholar Rock Stock Jumps On Additional Data From Pivotal Trial Of Muscular Dystrophy Treatment
Tickers NEWS SRRK
Tags disease Briefs why it's moving
From Benzinga
Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst
Tickers AZN BMY CATX LLY
Tags Market News Health Care LLY
From Benzinga
Cannabis Takes On Superbugs: Could This New Drug 'Change Infection Treatment Forever'?
Tags Benzinga Dr/ Dana Lambert Silvanex
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today